ALBEMARLE CORPORATION (ALB) — financial distillation
Annual history (10-K)
Quarterly history (10-Q)
Two headline lines are shown to start. Click any item in a legend to add or remove it — every figure on the chart is one the table below also carries, for the period it names.
In brief, from the full filed history
- Revenue grew from $2.47B (period ending 2008-12-31) to $5.14B (period ending 2025-12-31) — a 4.4% annual pace across 17 year(s) of filed history.
- Net margin turned from a 7.9% margin to a loss (-9.9%) over that same span.
- Across 52 tracked quarters, the strongest was $2.58B (quarter ending 2023-03-31) and the weakest was $445.3M (quarter ending 2009-06-30).
Annual — most recent 10-K
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $5.14B | 2025-12-31 | 10-K | 0000915913-26-000018 |
| Gross profit | $668.7M | 2025-12-31 | 10-K | 0000915913-26-000018 |
| Operating income | $-367.1M | 2025-12-31 | 10-K | 0000915913-26-000018 |
| Net income | $-510.6M | 2025-12-31 | 10-K | 0000915913-26-000018 |
| Diluted EPS | $-5.76 | 2025-12-31 | 10-K | 0000915913-26-000018 |
| Total assets | $16.37B | 2025-12-31 | 10-K | 0000915913-26-000018 |
| Cash & equivalents | $613.1M | 2019-12-31 | 10-K | 0000915913-20-000040 |
| Operating cash flow | $1.28B | 2025-12-31 | 10-K | 0000915913-26-000018 |
Quarterly — most recent 10-Q
| Line | Value | Period ends | Form | Filing |
|---|---|---|---|---|
| Revenue | $1.74B | 2026-06-30 | 10-Q | 0000915913-26-000102 |
| Gross profit | $590.3M | 2026-06-30 | 10-Q | 0000915913-26-000102 |
| Operating income | $452.9M | 2026-06-30 | 10-Q | 0000915913-26-000102 |
| Net income | $480.0M | 2026-06-30 | 10-Q | 0000915913-26-000102 |
| Diluted EPS | $3.52 | 2026-06-30 | 10-Q | 0000915913-26-000102 |
| Total assets | $15.91B | 2026-06-30 | 10-Q | 0000915913-26-000102 |
| Cash & equivalents | $1.63B | 2026-06-30 | 10-Q | 0000915913-26-000102 |
| Operating cash flow | $346.2M | 2026-03-31 | 10-Q | 0000915913-26-000072 |
Reading
The figures above are taken directly from filings with the U.S. Securities and Exchange Commission. The reading below was generated by a local language model from only those figures; it introduces no numbers of its own. It is not investment advice.
Albemarle Corporation’s business scale is substantial, with total assets amounting to $16.37 billion as of the latest annual filing. The company’s revenue has grown at a modest pace of 4.4% annually over the past 17 years, rising from $2.47 billion in 2008 to $5.14 billion in 2025. However, this growth is accompanied by a concerning trend in net income margins, which have deteriorated from a robust 7.9% in 2008 to a loss of -9.9% as of the most recent annual period.
The multi-year trajectory reveals periods of significant fluctuation, with notable revenue increases during 2015-2016 and a substantial surge in 2022, followed by a sharp decline in 2023 and 2024 before stabilizing slightly in 2025. The company’s operating income and net income have also shown volatility, with the most recent quarterly figures indicating a return to profitability after a string of losses.
In the upcoming filings, investors should monitor the company’s ability to stabilize its financial performance, particularly its net income margins, and its capacity to manage costs effectively to improve profitability. Additionally, the trend in revenue growth will be crucial to observe, as it has been relatively subdued despite the significant increase in total assets.
Source: SEC EDGAR company facts for CIK 0000915913 · filings index